Daniel A. Pryor - Nov 4, 2021 Form 4 Insider Report for Colfax CORP (ENOV)

Role
EVP, Strategy & Business Dev.
Signature
/s/ Bradley Tandy, Attorney-in-Fact
Stock symbol
ENOV
Transactions as of
Nov 4, 2021
Transactions value $
-$47,850
Form type
4
Date filed
11/8/2021, 05:00 PM
Previous filing
Nov 4, 2021
Next filing
Nov 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENOV Common stock, par value $.001 Options Exercise $864K +16.6K +10.12% $52.02 181K Nov 4, 2021 Direct
transaction ENOV Common stock, par value $.001 Sale -$180K -3.36K -1.86% $53.59 178K Nov 4, 2021 Direct F1, F2
transaction ENOV Common stock, par value $.001 Sale -$701K -13K -7.3% $54.09 165K Nov 4, 2021 Direct F1, F3
transaction ENOV Common stock, par value $.001 Sale -$16.2K -300 -0.18% $54.14 164K Nov 4, 2021 Direct F1, F4
transaction ENOV Common stock, par value $.001 Options Exercise $379K +7.29K +4.44% $52.02 172K Nov 5, 2021 Direct
transaction ENOV Common stock, par value $.001 Sale -$61.7K -1.15K -0.67% $53.44 170K Nov 5, 2021 Direct F1, F5
transaction ENOV Common stock, par value $.001 Sale -$328K -6.05K -3.55% $54.22 164K Nov 5, 2021 Direct F1, F6
transaction ENOV Common stock, par value $.001 Sale -$4.87K -90 -0.05% $54.08 164K Nov 5, 2021 Direct F1
holding ENOV Common stock, par value $.001 2.31K Nov 4, 2021 By 401K Plan
holding ENOV Common stock, par value $.001 1K Nov 4, 2021 By trust for daughter
holding ENOV Common stock, par value $.001 1K Nov 4, 2021 By trust for daughter
holding ENOV Common stock, par value $.001 1K Nov 4, 2021 By trust for son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENOV Employee Stock Option (right to buy) Options Exercise $0 -16.6K -14.88% $0.00 95.1K Nov 4, 2021 Common stock, par value $.001 16.6K $52.02 Direct F7
transaction ENOV Employee Stock Option (right to buy) Options Exercise $0 -7.29K -7.67% $0.00 87.8K Nov 5, 2021 Common stock, par value $.001 7.29K $52.02 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.08 to $54.02, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F3 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.22, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
F4 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.10 to $54.19, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
F5 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.94, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4.
F6 The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.04 to $54.43, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4.
F7 The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 2/16/2015.